Mission to ZERO Aims to Reset National Benchmark
Magnolia launches nationwide initiative to raise awareness of patient safety risks caused by false-positive diagnostic results for sepsis. The goal is to drive change by reducing the national blood culture contamination benchmark, while partnering with hospitals in their mission to eliminate blood culture contamination and false positive CLABSI reporting.
Newsweek Selects Steripath as a 2020 Best Product in Infection Prevention
The Best Health Care series by Newsweek and The Leapfrog Group highlights the nation's most promising products and technologies to help patients and healthcare workers avoid infection.
Introducing Steripath Gen2 with Integrated Syringe
The trusted solution for reducing blood culture contamination is now optimized for ‘hard stick’ patients and syringe collection protocols as the only diversion device with a preassembled, integrated syringe configuration.
Stanford Health Care Presents Unprecedented Study Results with Steripath Gen2 ISDD to Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria
Steripath clinical study reports a 0.0% blood culture contamination rate and zero false-positive CLABSIs, supporting PACCARB’s mission to prevent antibiotic-resistance Download Study Seattle, WA,…